Citation: C. Taverna et al., PETECHIAE, SUFFUSIONS AND CYTARABINE-INDUCED ERYTHEMA IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA, Schweizerische medizinische Wochenschrift, 128(27-28), 1998, pp. 1117-1117
Authors:
HEUBERGER W
BERARDI S
JACKY E
PEY P
KRAHENBUHL S
Citation: W. Heuberger et al., INCREASED URINARY-EXCRETION OF CARNITINE IN PATIENTS TREATED WITH CISPLATIN, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 503-508
Authors:
FOPP M
FEY MF
BACCHI M
CAVALLI F
GMUER J
JACKY E
SCHMID L
TICHELLI A
TOBLER A
TSCHOPP L
VONFLIEDNER V
GRATWOHL A
Citation: M. Fopp et al., POSTREMISSION THERAPY OF ADULT ACUTE MYELOID-LEUKEMIA - ONE CYCLE OF HIGH-DOSE VERSUS STANDARD-DOSE CYTARABINE, Annals of oncology, 8(3), 1997, pp. 251-257
Authors:
FENAUX P
CHASTANG C
CASTAIGNE S
ARCHIMBAUD E
LINK H
FEY M
GUERCI A
FEGUEUX N
BOWEN D
LOWENBERG B
GARDIN C
MALOISEL F
STAMATOULAS A
STOPPA AM
SADOUN A
JACKY E
GANSER A
AUZANNEAU G
CHOMIENNE C
DEGOS L
Citation: P. Fenaux et al., LONG-TERM FOLLOW-UP CONFIRMS THE SUPERIORITY OF ATRA COMBINED WITH CHEMOTHERAPY (CT) OVER CT ALONE IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - (APL-91 TRIAL), Blood, 90(10), 1997, pp. 1476-1476
Authors:
PESTALOZZI BC
KRESTIN GP
SCHANZ U
JACKY E
GMUR J
Citation: Bc. Pestalozzi et al., HEPATIC-LESIONS OF CHRONIC DISSEMINATED CANDIDIASIS MAY BECOME INVISIBLE DURING NEUTROPENIA, Blood, 90(10), 1997, pp. 3858-3864
Authors:
BERARDI S
HEUBERGER W
JACKY E
KRAHENBUHL S
Citation: S. Berardi et al., RENAL CARNITINE EXCRETION IS A MARKER FOR CISPLATIN-INDUCED TUBULAR NEPHROTOXICITY, The FASEB journal, 10(3), 1996, pp. 2715-2715
Authors:
CHRIST E
LINKA A
JACKY E
SPEICH R
MARINCEK B
SCHAFFNER A
Citation: E. Christ et al., SWEETS-SYNDROME INVOLVING THE MUSCULOSKELETAL SYSTEM DURING TREATMENTOF PROMYELOCYTIC LEUKEMIA WITH ALL-TRANS-RETINOIC ACID, Leukemia, 10(4), 1996, pp. 731-734
Authors:
JOST LM
JACKY E
DOMMANNSCHERRER C
HONEGGER HP
MAURER R
SAUTER C
STAHEL RA
Citation: Lm. Jost et al., SHORT-TERM WEEKLY CHEMOTHERAPY FOLLOWED BY HIGH-DOSE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOBLASTIC AND BURKITT LYMPHOMAS IN ADULT PATIENTS, Annals of oncology, 6(5), 1995, pp. 445-451
Authors:
STAHEL RA
JOST LM
CERNY T
PICHERT G
HONEGGER H
TOBLER A
JACKY E
FEY M
PLATZER E
Citation: Ra. Stahel et al., RANDOMIZED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HIGH-RISK LYMPHOID MALIGNANCIES, Journal of clinical oncology, 12(9), 1994, pp. 1931-1938
Authors:
WERNLI M
TICHELLI A
VONFLIEDNER V
DELRE GB
CHAPUIS B
FEY MF
FOPP M
GMUR J
GROB JP
JACKY E
PEDRAZZINI A
SCHMID L
SENN HJ
TOBLER A
GRATWOHL A
Citation: M. Wernli et al., INTENSIVE INDUCTION CONSOLIDATION THERAPY WITHOUT MAINTENANCE IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A PILOT ASSESSMENT/, British Journal of Haematology, 87(1), 1994, pp. 39-43
Authors:
WERNLI M
FEY MF
TOBLER A
VONROHR A
BARGETZI M
TICHELLI A
FEHR J
GMUR J
JACKY E
BERIS P
CHAPUIS B
HESS U
DELACRETAZ F
JOTTERAND M
SCHAPIRA M
CAVALLI F
MAIBACH R
RUFENER B
GRATWOHL A
Citation: M. Wernli et al., THE LIMIT OF DOSE-INTENSIFICATION IN THE TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA DESPITE GROWTH-FACTOR THERAPY, Blood, 84(10), 1994, pp. 10000144-10000144
Authors:
JOST LM
PICHERT G
REICHLIN M
MULLER E
JACKY E
HONEGGER HP
GMUR J
STAHEL RA
Citation: Lm. Jost et al., 5 YEARS OF DOSE INTENSIFICATION AND AUTOLOGOUS BONE-MARROW OR PERIPHERAL STEM-CELL TRANSPLANTATION IN MALIGNANT-LYMPHOMA WITH HIGH-RISK OF RELAPSE, Schweizerische medizinische Wochenschrift, 123(18), 1993, pp. 932-940
Authors:
FENAUX P
LEDELEY MC
CASTAIGNE S
ARCHIMBAUD E
CHOMIENNE C
LINK H
GUERCI A
DUARTE M
DANIEL MT
BOWEN D
HUEBNER G
BAUTERS F
FEGUEUX N
FEY M
SANZ M
LOWENBERG B
MALOISEL F
AUZANNEAU G
SADOUN A
GARDIN C
BASTION Y
GANSER A
JACKY E
DOMBRET H
CHASTANG C
DEGOS L
Citation: P. Fenaux et al., EFFECT OF ALL TRANSRETINOIC ACID IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - RESULTS OF A MULTICENTER RANDOMIZED TRIAL, Blood, 82(11), 1993, pp. 3241-3249